The European Medicines Agency has accepted Teva Pharmaceutical Industries Ltd.'s (NYSE: TEVA) marketing authorization application for TEV-'749, a long-acting injectable ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE